ETS1 and metabolic dysfunction-associated steatohepatitis: Although further studies are needed to elucidate the mechanism, the findings of this study indicated that Ets-1 might serve as a new target in the pathogenesis of NASH, thus providing a basis for the design of new strategies to cure this disease.